Saudi FDA first to approve Zynpexos for multiple myeloma
The Saudi Food and Drug Authority becomes the world's first regulator to approve Zynpexos for treating relapsed or refractory multiple myeloma.
We haven't written up this one. Ajel English has the full story — the link below goes straight to it.